SCHEMBL12654495

SCHEMBL12654495

CCN1CCCNc2nc(C3(C)C=C(Cl)C=CC3)ccc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16775802 0.75 SMN1; SMN2 (0.36) —
SCHEMBL1816731 0.66 GAK (0.38) —
SCHEMBL1841385 0.65 KCNH2 (0.39) —
SCHEMBL20733150 0.64 PTGER4 (0.39) —
SCHEMBL20733299 0.63 EGLN2 (0.39) —
SCHEMBL19670139 0.62 MAP4K4 (0.37) —
SCHEMBL19670142 0.62 MAP4K4 (0.42) —
SCHEMBL19670180 0.61 HRH3 (0.34) —
SCHEMBL20733111 0.60 MAPK14 (0.36) —
SCHEMBL20733270 0.60 PDE10A (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011059839-A1 BICYCLIC PYRIDINES AND ANALOGS AS SIRTUIN MODULATORS SIRTRIS PHARMACEUTICALS, INC. (US) 2011-05-19 — — WO disclosed
Send feedback